Previous Section
Clinical Trials
11. Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.
- Author
- Attar EC; De Angelo DJ; Supko JG; D'Amato F; Zahrieh D; Sirulnik A; Wadleigh M; Ballen KK; McAfee S; Miller KB; Levine J; Galinsky I; Trehu EG; Schenkein D; Neuberg D; Stone RM; Amrein PC;
- Institution
- Hematology/Oncology Unit, Massachusetts General Hospital, Boston, MA 02114, USA. eattar@partners.org
- Journal
- Clin Cancer Res. 2008 Mar 1;14(5):1446-54.
- Abstract URL
- Click here to view abstract
12. Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).
- Author
- Miyawaki S; Kawai Y; Takeshita A; Komatsu N; Usui N; Arai Y; Ishida F; Morii T; Kano Y; Ogura M; Doki N; Ohno R;
- Institution
- Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma 371-0821, Japan. miyawaki@mail.wind.ne.jp
- Journal
- Int J Hematol. 2007 Nov;86(4):343-7.
- Abstract URL
- Click here to view abstract
13. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
- Author
- Creutzig U; Buchner T; Sauerland MC; Zimmermann M; Reinhardt D; Dohner H; Schlenk RF;
- Institution
- Pediatric Hematology/Oncology, Children's Hospital, University of Munster, Munster, Germany. ursula@creutzig.de
- Journal
- Cancer. 2008 Feb 1;112(3):562-71.
- Abstract URL
- Click here to view abstract
14. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
- Author
- Valcarcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Pinana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simon JA; Sierra J; Valcarcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Pinana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simon JA; Sierra J;
- Institution
- Hospital de la Santa Creu i Sant Pau, Universitat Autonoma Barcelona, Barcelona, Spain. dvalcarcel@santpau.es
- Journal
- J Clin Oncol. 2008 Feb 1;26(4):577-84. Epub 2007 Dec 17.
- Abstract URL
- Click here to view abstract
15. Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.
- Author
- Frankel A; Liu JS; Rizzieri D; Hogge D; Frankel A; Liu JS; Rizzieri D; Hogge D;
- Institution
- Scott & White Cancer Research Institute, Temple, TX, USA.
- Journal
- Leuk Lymphoma. 2008 Mar;49(3):543-53.
- Abstract URL
- Click here to view abstract
16. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
- Author
- Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB; Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB;
- Institution
- Department of Pediatrics, Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. smallt@mskcc.org
- Journal
- Biol Blood Marrow Transplant. 2007 Feb;13(2):235-44.
- Abstract URL
- Click here to view abstract
17. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
- Author
- Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D; Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D;
- Institution
- University of Cologne, Cologne, Germany. oliver.cornely@uni-koeln.de
- Journal
- N Engl J Med. 2007 Jan 25;356(4):348-59.
- Abstract URL
- Click here to view abstract
18. Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
- Author
- Thomas X; Raffoux E; Botton S; Pautas C; Arnaud P; de Revel T; Reman O; Terre C; Corront B; Gardin C; Le QH; Quesnel B; Cordonnier C; Bourhis JH; Elhamri M; Fenaux P; Preudhomme C; Michallet M; Castaigne S; Dombret H;
- Institution
- Department of Hematology, Hopital Edouard Herriot, Lyon, France. xavier.thomas@chu-lyon.fr
- Journal
- Leukemia. 2007 Mar;21(3):453-61. Epub 2007 Jan 25.
- Abstract URL
- Click here to view abstract
19. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
- Author
- Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG; Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG;
- Institution
- ETSU Quillen College of Medicine, Johnson City, Tennessee, USA. scastell@wfubmc.edu
- Journal
- Pediatr Blood Cancer. 2008 Jan;50(1):9-16.
- Abstract URL
- Click here to view abstract
20. Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia.
- Author
- Roboz GJ; Giles FJ; Ritchie EK; Allen-Bard S; Curcio TJ; Wilkes MA; Park SL; Kantarjian HM; Faderl S; Ravandi F; Kelner MJ; Feldman EJ;
- Institution
- Weill Medical College of Cornell University, The New York Presbyterian Hospital, New York, NY 10021, USA. gar2001@med.cornell.edu
- Journal
- J Clin Oncol. 2007 Jan 1;25(1):10-5. Epub 2006 Dec 4.
- Abstract URL
- Click here to view abstract
